For questions about financial assistance, call 1-866-MY-APL-ASSIST
Jonathan is an adult with PNH who’s taken EMPAVELI
The ApellisAssist® support team will work with you to identify the right programs for affordable access to treatment.
ApellisAssist has you covered. There are multiple programs to provide eligible patients with financial assistance and offer benefits investigation support.
You may pay as little as
$0 for EMPAVELI
with our Copay Program‡
If you don’t have insurance or your insurance only provides limited coverage, the Apellis Patient Assistance Program may be able to help you obtain EMPAVELI at no cost.§
The Apellis Bridge Program can help with interruptions or changes in insurance. If your insurance provider or your plan has changed, you may experience an interruption in coverage. If this occurs, you could be eligible for a temporary supply of EMPAVELI through the Apellis Bridge Program.§
ApellisAssist helps you access EMPAVELI and explore affordability options. Call the ApellisAssist team at 1-866-MY-APL-ASSIST (1-866-692-7527) from 8 AM-8 PM ET, Monday-Friday. ApellisAssist can also connect you to a pharmacist who is available 24 hours a day.
*The Apellis Copay Program is for eligible patients who are enrolled in the ApellisAssist program, are commercially insured, and who are not covered under government insurance programs such as Medicaid, Medicare, CHIP, VA/DoD, or TRICARE.
†Additional terms and conditions apply. Program terms are subject to change.
‡Terms and Conditions apply. Program terms subject to change. Subject to annual benefit limit.
§Terms and conditions apply. Program terms are subject to change.
With EMPAVELI, you’re not alone. When you enroll in ApellisAssist, you’ll get dedicated support every step of the way.
Your ACE is there for you from the start. They are trained professionals with nursing backgrounds that offer:
“No matter where you are in your journey, I am always at your side.”
Meet Megan
“No matter where you are in your journey, I am always at your side.”
Meet Tracey
“One of the things that I love most about being an ACE is the ongoing relationships.”
Meet Mollie
“I want patients to feel as comfortable and confident as possible moving forward.”
Meet Niki
“As we partnered together, it was amazing to watch this patient’s confidence build.”
Meet Kristen
“I provide initial trainings and ongoing support and education while they remain on therapy.”
Meet Mary R
“My role as an ACE is to help you through every step of your treatment journey, including self-infusion training.”
Meet Chrissi
“When patients share a special milestone, I just love celebrating those special moments together.”
Through ApellisAssist, a Care Coordinator will:
Care Coordinators and ACEs do not give medical advice. Talk to your doctor for treatment-related questions.
Insurance questions? In need of financial assistance? Call an ApellisAssist representative at 1-866-MY-APL-ASSIST (1-866-692-7527) to connect with your Care Coordinator about insurance questions or financial assistance programs that are available for eligible patients.
Our ApellisAssist team offers support to help you obtain any vaccinations recommended before starting EMPAVELI.
Because EMPAVELI affects part of the immune system, certain vaccines are required to help protect you against serious infections.
The Vaccine Coordinator through a specialty pharmacy will help by:
The EMPAVELI REMS Program
The FDA requires the REMS (Risk Evaluation and Mitigation Strategy) to ensure your safety when using EMPAVELI.
“I’m thankful for how efficient and streamlined the support from ApellisAssist has been. It’s amazing the level of support there is from the Care Coordinator to the fact that I have a number I can call if I need anything or have any questions.”
Jonathan is an adult with PNH who’s taken EMPAVELI
CHIP=Children’s Health Insurance Program; DoD=Department of Defense; PNH=paroxysmal nocturnal hemoglobinuria; VA=Department of Veterans Affairs.
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections.
EMPAVELI increases your chance of getting serious infections caused by encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or cause death if not recognized and treated early.
Your healthcare provider will give you a Patient Safety Card about the risk of serious infections. Carry it with you at all times during treatment and for 2 months after your last EMPAVELI dose. Your risk of serious infections may continue for several weeks after your last dose of EMPAVELI. It is important to show this card to any healthcare provider who treats you. This will help them diagnose and treat you quickly.
EMPAVELI is only available through a program called the EMPAVELI Risk Evaluation and Mitigation Strategy (REMS). Before you can take EMPAVELI, your healthcare provider must enroll in the EMPAVELI REMS program, counsel you about the risk of serious infections caused by certain bacteria, give you information about the symptoms of serious infections, make sure that you are vaccinated against serious infections caused by encapsulated bacteria and that you receive antibiotics if you need to start EMPAVELI right away and you are not up to date on your vaccines, and give you a Patient Safety Card about your risk of serious infections.
Do not take EMPAVELI if you:
Before you take EMPAVELI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment.
If you stop taking EMPAVELI, your healthcare provider will need to monitor you closely for at least 8 weeks after stopping EMPAVELI. Stopping treatment with EMPAVELI may cause a breakdown of red blood cells due to PNH.
Symptoms or problems that can happen due to red blood cell breakdown include:
EMPAVELI can cause serious side effects including allergic reactions. Allergic reactions can happen during your EMPAVELI infusion. Stop your EMPAVELI infusion and tell your healthcare provider or get emergency medical care right away if you get any of these symptoms during your EMPAVELI infusion:
The most common side effects in people with PNH treated with EMPAVELI include injection-site reactions; infections; diarrhea; pain in the stomach (abdomen); respiratory tract infection; pain in the arms, hands, legs, or feet; low potassium in blood; tiredness; viral infection; cough; joint pain; dizziness; headache; and rash.
These are not all of the possible side effects of EMPAVELI. Tell your healthcare provider about any side effect that bothers you or that does not go away.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
EMPAVELI is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH).
Please see full Prescribing Information, including Boxed WARNING regarding risk of serious infections, and Medication Guide for additional information.
By submitting this form, I acknowledge that I have reviewed, understood, and agree to the below guidelines, that I am at least 18 years of age and am legally competent to enter into this agreement, that I own all rights to the content submitted, and that I have received permission to submit the content from any other individual appearing in my submission for use by Apellis Pharmaceuticals, Inc. (“Apellis”), as set forth below.
Apellis can take, collect and use any content I have submitted to this webpage, including my photographs, film or recordings taken of my image and voice, my quotation or testimonial, as well as any personal health information contained in such photographs, film or recordings or provided on this submission form (collectively, “My Content and Information”). Apellis reserves the right to not post or use My Content and Information.
Apellis and its subsidiaries, affiliates, licensees, successors, assignees and those acting with its authority, have the right to use, re-use, broadcast, display and publish My Content and Information on social media, websites, displays, and emails. I waive all rights that I may have to claims for payment or royalties in connection with the posting or other usage of My Content and Information on these platforms. Apellis will contact me by e-mail or phone if it would like to feature My Content and Information elsewhere.
Any content that I submit to Apellis may be edited or excerpted in Apellis’ sole discretion to align with promotional requirements and the intended use of this site. I waive all rights in My Content and Information, including any right to inspect or approve My Content and Information prior to use or dissemination by Apellis. If significant changes are required, Apellis may contact me via e-mail or phone. Apellis will not use my e-mail address or phone number for any other purpose, unless I have separately opted into receiving communications from Apellis.
Adverse Events (“AEs”): Apellis will address any adverse events or side effects mentioned within submissions according to FDA regulations. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Sign up to join the EMPAVELI PNH community:
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections.
EMPAVELI increases your chance of getting serious infections caused by encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or cause death if not recognized and treated early.
Your healthcare provider will give you a Patient Safety Card about the risk of serious infections. Carry it with you at all times during treatment and for 2 months after your last EMPAVELI dose. Your risk of serious infections may continue for several weeks after your last dose of EMPAVELI. It is important to show this card to any healthcare provider who treats you. This will help them diagnose and treat you quickly.
EMPAVELI is only available through a program called the EMPAVELI Risk Evaluation and Mitigation Strategy (REMS). Before you can take EMPAVELI, your healthcare provider must enroll in the EMPAVELI REMS program, counsel you about the risk of serious infections caused by certain bacteria, give you information about the symptoms of serious infections, make sure that you are vaccinated against serious infections caused by encapsulated bacteria and that you receive antibiotics if you need to start EMPAVELI right away and you are not up to date on your vaccines, and give you a Patient Safety Card about your risk of serious infections.
Do not take EMPAVELI if you:
Before you take EMPAVELI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment.
If you stop taking EMPAVELI, your healthcare provider will need to monitor you closely for at least 8 weeks after stopping EMPAVELI. Stopping treatment with EMPAVELI may cause a breakdown of red blood cells due to PNH.
Symptoms or problems that can happen due to red blood cell breakdown include:
EMPAVELI can cause serious side effects including allergic reactions. Allergic reactions can happen during your EMPAVELI infusion. Stop your EMPAVELI infusion and tell your healthcare provider or get emergency medical care right away if you get any of these symptoms during your EMPAVELI infusion:
The most common side effects in people with PNH treated with EMPAVELI include injection-site reactions; infections; diarrhea; pain in the stomach (abdomen); respiratory tract infection; pain in the arms, hands, legs, or feet; low potassium in blood; tiredness; viral infection; cough; joint pain; dizziness; headache; and rash.
These are not all of the possible side effects of EMPAVELI. Tell your healthcare provider about any side effect that bothers you or that does not go away.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
EMPAVELI is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH).
Please see full Prescribing Information, including Boxed WARNING regarding risk of serious infections, and Medication Guide for additional information.